You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rubella

Showing 1 - 25 of 262
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))

Not yet recruiting
  • Mumps
  • +2 more
  • MMR booster vaccination (as M-M-R-VaxPro)
  • Zürich, Switzerland
    Epidemiology, Biostatistics and Prevention Institute University
Jun 8, 2023

Typhoid, Cholera, Measles Trial (Oral Cholera Vaccine (OCV), Typhoid Conjugate Vaccine (TCV), Measles and Rubella (MR))

Not yet recruiting
  • Typhoid
  • +3 more
  • Oral Cholera Vaccine (OCV)
  • +2 more
  • (no location specified)
Mar 5, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

Respiratory Tract Infections, Infections, Allergy Trial in Geneva (Measles-Mumps-Rubella vaccine (MMR))

Not yet recruiting
  • Respiratory Tract Infections
  • +3 more
  • Measles-Mumps-Rubella vaccine (MMR)
  • Geneva, Switzerland
    University Hospitals of Geneva
Feb 24, 2023

Measles; Mumps; Rubella; Chickenpox Trial in United States (Investigational MMRV(H)NS vaccine, Investigational MM(H)RVNS

Recruiting
  • Measles; Mumps; Rubella; Chickenpox
  • Investigational MMRV(H)NS vaccine
  • +3 more
  • Jonesboro, Arkansas
  • +9 more
Jan 16, 2023

Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi

Active, not recruiting
  • Human Papilloma Virus Infection Type 16
  • +4 more
  • HPV+MMR（0d），HPV（6m）
  • +2 more
  • Shaoxing, Zhejiang, China
  • +1 more
Mar 14, 2022

Eight Years After Vaccination of Children 12 to 23 Months With

Not yet recruiting
  • Measles Vaccine
    • (no location specified)
    Dec 9, 2021

    Meales-mumps-rubella Vaccine Trial in Copenhagen, Herlev (MMRvaxpro, Placebo)

    Completed
    • Meales-mumps-rubella Vaccine
    • MMRvaxpro
    • Placebo
    • Copenhagen, Copenhagen Ø, Denmark
    • +1 more
    Jan 12, 2022

    Measles, Rubella, Vaccination Trial in Fajara (Measles Rubella Vaccine (MRV-SC), MRV-MNP, PLA-MNP)

    Recruiting
    • Measles
    • +3 more
    • Measles Rubella Vaccine (MRV-SC)
    • +3 more
    • Fajara, Gambia
      Medical Research Center The Gambia at LSHTM
    Oct 12, 2021

    IsThird Dose of MMRV Vaccine Beneficial for Adult Population in

    Not yet recruiting
    • Vaccination Failure
    • Vaccine Response Impaired
    • Serology for antibody levels - Baseline
    • +3 more
    • (no location specified)
    Jun 26, 2023

    Childhood Cancer, Multiple Diseases Trial in New York (Immunization Schedule patients <7 years., Immunization Schedule patients

    Active, not recruiting
    • Childhood Cancer
    • Multiple Diseases
    • Immunization Schedule patients <7 years.
    • +2 more
    • New York, New York
      Memorial Sloan-Kettering Cancer Center 1275 York Avenue
    Aug 9, 2022

    Malaria, Malaria Vaccines Trial in Kintampo, Kumasi (Vitamin A, Candidate Plasmodium falciparum malaria vaccine, MR-Vac)

    Completed
    Has Results
    • Malaria
    • Malaria Vaccines
    • Vitamin A
    • +3 more
    • Kintampo, Ghana
    • +1 more
    Sep 7, 2021

    Measles, Rubella, Rubella Syndrome, Congenital Trial in Chandpur (Measles-rubella (MR) vaccine at 6 and 9 months,

    Completed
    • Measles
    • +2 more
    • Measles-rubella (MR) vaccine at 6 and 9 months
    • Measles-rubella (MR) vaccine at 9 months
    • Chāndpur, Bangladesh
      Icddr,B
    Dec 28, 2020

    Dengue, Dengue Hemorrhagic Fever Trial in Mexico (Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus, DTaP

    Completed
    Has Results
    • Dengue
    • Dengue Hemorrhagic Fever
    • Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus
    • +4 more
    • Acapulco, Guerrero, Mexico
    • +3 more
    Mar 15, 2022

    Ontogeny of Measles Immunity in Infants

    Completed
    • Measles
    • Attenuvax (Measles Virus Live Vaccine, 0.5ml subcutaneous)
    • MMR-II (Measles-Mumps-Rubella Virus Live Vaccine, 0.5ml subcutaneous)
    • Palo Alto, California
    • +1 more
    Jun 6, 2022

    Dengue, Dengue Hemorrhagic Fever, Yellow Fever Trial in Cali, Lima (Live, attenuated dengue serotype 1, 2, 3, and 4 virus,

    Completed
    Has Results
    • Dengue
    • +2 more
    • Live, attenuated dengue serotype 1, 2, 3, and 4 virus
    • +8 more
    • Cali, Colombia
    • +1 more
    Mar 15, 2022

    Mumps Trial in Hezhou (Mumps vaccine, measles, mumps and rubella combined vaccine, live)

    Completed
    • Mumps
    • Mumps vaccine
    • measles, mumps and rubella combined vaccine, live
    • Hezhou, Guangxi, China
      Hezhou Center for Disease Prevention and Control
    Aug 16, 2021

    Encephalitis, Japanese, Measles, Mumps Trial in Manila (Live attenuated SA 14-14-2 Japanese Encephalitis vaccine, Measles,

    Completed
    Has Results
    • Encephalitis, Japanese
    • +3 more
    • Live attenuated SA 14-14-2 Japanese Encephalitis vaccine
    • Measles, mumps, rubella vaccine
    • Manila, Philippines
      Research Institute for Tropical Medicine
    Sep 18, 2020

    Meningococcal Infection (Healthy Volunteers) Trial in Middelburg (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)

    Recruiting
    • Meningococcal Infection (Healthy Volunteers)
    • Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
    • +11 more
    • Middelburg, South Africa
      Investigational Site Number: 7100001
    Apr 4, 2023

    Biomarkers of Trained Immunity Following MMR Vaccination

    Completed
    • Covid19
    • Heterologous stimuli
    • Neutralization assay
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 24, 2021

    Rubella, Measles Trial in Natal, Rio de Janeiro (Measles and Rubella vaccine, Measles, Mumps and Rubella vaccine)

    Completed
    • Rubella
    • Measles
    • Measles and Rubella vaccine
    • Measles, Mumps and Rubella vaccine
    • Natal, Rio Grande Do Norte, Brazil
    • +1 more
    Aug 12, 2020

    Hand, Foot and Mouth Disease Trial in Ankang (Concomitant administration of EV71vaccine with EPI vaccines, Single injection of

    Completed
    • Hand, Foot and Mouth Disease
    • Concomitant administration of EV71vaccine with EPI vaccines
    • +2 more
    • Ankang, Shaanxi, China
      Hanbin District Center for Disease Control and Prevention
    Jul 26, 2021

    Common Wart, Plantar Wart Trial in Assiut (Measles-Mumps-Rubella Vaccine, cryotherapy)

    Completed
    • Common Wart
    • Plantar Wart
    • Measles-Mumps-Rubella Vaccine
    • cryotherapy
    • Assiut, Egypt
      Assiut university hospitals
    Jun 13, 2020

    Infectious Diseases Trial in Oxford (DTaP/IPV/Hib vaccine, 13 valent Pneumococcal Conjugate Vaccine, Rotavirus vaccine)

    Completed
    • Infectious Diseases
    • DTaP/IPV/Hib vaccine
    • +5 more
    • Oxford, Oxfordshire, United Kingdom
      Centre for Clinical Vaccinology and Tropical Medicine
    Sep 17, 2021

    Chikungunya Virus Infection Trial in Austria, Germany (MV-CHIK low dose, MV-CHIK high dose, Priorix®)

    Completed
    Has Results
    • Chikungunya Virus Infection
    • MV-CHIK low dose
    • +3 more
    • Graz, Austria
    • +3 more
    Oct 15, 2021